Data against a Common Assumption: Xenogeneic Mouse Models Can Be Used to Assay Suppression of Immunity by Human MSCs. Academic Article

abstract

• Much of what we know about immunology suggests that little is to be gained from experiments in which human cells are administered to immunocompetent mice. Multiple reports have demonstrated that this common assumption does not hold for experiments with human mesenchymal stem/stromal cells (hMSCs). The data demonstrate that hMSCs can suppress immune responses to a variety of stimuli in immunocompetent mice by a range of different mechanisms that are similar to those employed by mouse MSCs. Therefore, further experiments with hMSCs in mice will make it possible to generate preclinical data that will improve both the efficacy and safety of the clinical trials with the cells that are now in progress.

authors

• Lee, Ryang
• Prockop, Darwin

published proceedings

• Mol Ther

author list (cited authors)

• Prockop, D. J., Oh, J. Y., & Lee, R. H.

citation count

• 22

complete list of authors

• Prockop, Darwin J||Oh, Joo Youn||Lee, Ryang Hwa

publication date

• January 2017

publisher

• Elsevier  Publisher

published in

• MOLECULAR THERAPY  Journal

keywords

• Animals
• Disease Models, Animal
• Heterografts
• Humans
• Immune System
• Immune Tolerance
• Immunity
• Immunomodulation
• Mesenchymal Stem Cells
• Mesenchymal Stromal Cells
• Mice
• Species Specificity
• Xenogeneic Models

PubMed Central ID

• 28647464

Digital Object Identifier (DOI)

• 10.1016/j.ymthe.2017.06.004

start page

• 1748

end page

• 1756

volume

• 25

issue

• 8

URL

• http://dx.doi.org/10.1016/j.ymthe.2017.06.004